EdenTree Asset Management’s Merck MRK Stock Holding History

EdenTree Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.42M	Sell	53,340 -41,000	-43%	-$4.73M	1.93%	21
2025 Q4	$9.93M	Sell	94,340 -83,875	-47%	-$7.87M	3.04%	8
2025 Q3	$15M	Buy	178,215 +57,350	+47%	+$4.72M	3.6%	6
2025 Q2	$9.56M	Buy	120,865 +15,000	+14%	+$1.19M	2.65%	14
2025 Q1	$9.5M	Buy	105,865 +26,225	+33%	+$2.45M	3.19%	7
2024 Q4	$7.92M	Hold	79,640	–	–	2.3%	19
2024 Q3	$9.04M	Buy	79,640 +73,840	+1,273%	+$8.77M	2.62%	14
2024 Q2	$718K	Hold	5,800	–	–	0.23%	61
2024 Q1	$765K	Sell	5,800 -10,200	-64%	-$1.26M	0.24%	62
2023 Q4	$1.74M	Buy	16,000 +500	+3%	+$51.9K	0.54%	35
2023 Q3	$1.6M	Sell	15,500 -10,000	-39%	-$1.08M	0.63%	35
2023 Q2	$2.94M	Buy	+25,500	New	+$2.9M	1.01%	30

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EdenTree Asset Management's MRK Position: Q1 2026 in Review

EdenTree Asset Management reduced its Merck (MRK) stake by 43% in Q1 2026, selling an estimated $4.73M and leaving 53,340 shares worth $6.42M. The position accounts for 1.93% of the portfolio, ranked #21.

EdenTree Asset Management first reported a position in MRK in Q2 2023 and has held it in 12 quarters since. The position peaked at $15M in Q3 2025. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

EdenTree Asset Management held 53,340 shares of Merck worth $6.42M as of Q1 2026.
EdenTree Asset Management sold 41,000 Merck shares in Q1 2026, an estimated $4.73M.
Merck made up 1.93% of EdenTree Asset Management's portfolio in Q1 2026, its #21 holding.
EdenTree Asset Management first reported a position in Merck in Q2 2023 and has held it in 12 quarters since.
EdenTree Asset Management's Merck position peaked at $15M in Q3 2025.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on EdenTree Asset Management's 13F filing for Q1 2026, filed 14 May 2026.